At the beginning of the funding cycle, the Global Fund allocates funding to eligible countries for HIV, tuberculosis and malaria programs. Additional funding may also be available for health systems.
In order to access the funding, countries are to meet eligibility and other requirements, some of which are outlined on this page.
Whether a country or region is eligible for Global Fund support is determined by their income level and disease burden. Countries may be eligible for funding for one, two or all three of the diseases.
See Eligibility for more information.
An eligible country is communicated an allocation, which is the amount of funding available for programs during the cycle. The Global Fund communicates allocations every three years and calculates allocations using a formula based on a country's disease burden and economic capacity, refined to account for important in-country factors.
See Allocation for more information.
Funding in addition to a country’s allocation may also be available. Catalytic investments are a portion of available funding set aside for programs and activities essential to achieve the aims of the Global Fund Strategy and partner plans, but not adequately accommodated through country allocations.
See Catalytic Investments for more information.
The Global Fund works closely with countries to help them achieve long-term sustainability of health programs, so they can maintain progress and continue to expand services after Global Fund support ends. Ultimately, ending the epidemics will only be achieved with sustainable health systems that are fully funded by countries through their own resources.
See Sustainability for more information.
The Global Fund proactively supports countries in planning for the successful transitions from Global Fund support. All upper-middle income countries regardless of disease burden and all lower-middle income country components with low or moderate disease burden, should begin or build upon transition preparations during the 2017-2019 period.
See Transition for more information.
To increase country ownership and build the sustainability of programs, our funding model includes a requirement for countries to commit to co-finance the response to the diseases. Evidence of the country’s commitment to co-financing is necessary in order to access their allocation.
See Co-Financing for more information.